If a patient asks about medical marijuana, how will you respond? Are you familiar with the legalities and science to advise your patient? The legalities are complex, but the bottom line is this: medical marijuana is gaining support nationwide.
Cannabidiol is used by a growing population for many ailments. Although not typically an emergency drug, it has important interactions and a few side effects that can be seen in the emergency department.
Cannabidiol (CBD) is one of two major constituents of marijuana and is the non-psychoactive component of cannabis. As its popularity has grown, questions about CBD from patients to their primary care clinicians have increased dramatically. As a patient advocate interpreting the available evidence, the primary care clinician needs to recognize how CBD differs from marijuana, what its clinical utility might be, and what its risks are.
This article will evaluate and assess medical marijuana, also called medical cannabis, and will cover benefits and risks, clinical considerations affecting its recommendation, and currently available evidence.
Plenty of medical associations have released position statements addressing medical marijuana, but many cite the lack of research into cannabis as a healthcare product as a barrier to writing comprehensive, evidence-based guidelines.
Rapidly changing state marijuana laws may challenge surgery centers to write ironclad policies regarding drug testing and screening. Any decision made one day could be put in peril by new or updated regulations the next day.